In the last week, the Biotech industry is down 2.1% with Amgen down the most at 2.4%. In the past year, the industry has gained 10%. Earnings are forecast to grow by 21% annually.
Has the U.S. Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Mon, 18 Mar 2024 | US$1.2t | US$167.4b | -US$22,071,849,383.64 | 13.9x | -53.2x | 7x |
Wed, 14 Feb 2024 | US$1.1t | US$168.9b | -US$20,817,013,760.70 | 18x | -54.6x | 6.7x |
Fri, 12 Jan 2024 | US$1.4t | US$204.8b | -US$22,495,274,678.00 | 19.2x | -64.1x | 7x |
Sun, 10 Dec 2023 | US$1.3t | US$204.6b | -US$22,091,414,218.00 | 18.7x | -58.3x | 6.3x |
Tue, 07 Nov 2023 | US$1.2t | US$203.9b | -US$22,185,418,652.00 | 18.9x | -56x | 6.1x |
Thu, 05 Oct 2023 | US$1.2t | US$207.3b | -US$13,076,809,948.00 | 16.7x | -94.9x | 6x |
Sat, 02 Sep 2023 | US$1.3t | US$207.6b | -US$12,424,624,459.00 | 18.4x | -104.2x | 6.2x |
Mon, 31 Jul 2023 | US$1.2t | US$186.0b | -US$15,168,211,533.00 | 14.7x | -76.1x | 6.2x |
Wed, 28 Jun 2023 | US$1.1t | US$186.3b | -US$16,125,527,732.00 | 13.5x | -69.1x | 6x |
Fri, 26 May 2023 | US$1.1t | US$185.9b | -US$15,950,003,280.00 | 11.5x | -71.8x | 6.2x |
Sun, 23 Apr 2023 | US$1.2t | US$198.4b | -US$3,214,788,122.00 | 13.9x | -370.1x | 6x |
Tue, 21 Mar 2023 | US$1.1t | US$199.3b | -US$3,748,498,766.00 | 12.7x | -301.2x | 5.7x |
Thu, 16 Feb 2023 | US$1.2t | US$202.5b | US$17.8m | 16.3x | 64811.8x | 5.7x |
Sat, 14 Jan 2023 | US$1.2t | US$203.7b | US$1.8b | 14.5x | 670.8x | 5.8x |
Mon, 12 Dec 2022 | US$1.1t | US$202.7b | US$1.4b | 14.6x | 811.7x | 5.6x |
Wed, 09 Nov 2022 | US$1.1t | US$204.5b | US$3.9b | 14.4x | 280.2x | 5.3x |
Fri, 07 Oct 2022 | US$1.1t | US$206.2b | US$5.5b | 15.1x | 193.6x | 5.1x |
Sun, 04 Sep 2022 | US$1.0t | US$206.4b | US$6.2b | 14.6x | 167.9x | 5x |
Tue, 02 Aug 2022 | US$1.0t | US$212.2b | US$11.4b | 15.4x | 90.7x | 4.9x |
Thu, 30 Jun 2022 | US$1.0t | US$212.2b | US$11.0b | 15.7x | 94.5x | 4.9x |
Sat, 28 May 2022 | US$1.0t | US$212.7b | US$11.1b | 16.1x | 92.8x | 4.8x |
Mon, 25 Apr 2022 | US$1.2t | US$226.6b | US$14.7b | 17.8x | 81.5x | 5.3x |
Wed, 23 Mar 2022 | US$1.3t | US$221.9b | US$10.6b | 19.8x | 122.3x | 5.9x |
Fri, 18 Feb 2022 | US$1.2t | US$216.4b | US$5.7b | 21.9x | 214.8x | 5.7x |
Sun, 16 Jan 2022 | US$1.3t | US$212.1b | US$2.5b | 24.4x | 527.3x | 6.2x |
Tue, 14 Dec 2021 | US$1.4t | US$211.9b | US$3.1b | 25.2x | 449.8x | 6.7x |
Thu, 11 Nov 2021 | US$1.5t | US$204.8b | -US$58,717,099.00 | 25.4x | -24760.2x | 7.1x |
Sat, 09 Oct 2021 | US$1.5t | US$196.3b | -US$2,607,286,814.00 | 23.3x | -558.7x | 7.4x |
Mon, 06 Sep 2021 | US$1.6t | US$196.4b | -US$2,275,254,373.56 | 22.4x | -705.5x | 8.2x |
Wed, 04 Aug 2021 | US$1.6t | US$197.0b | -US$1,413,253,338.58 | 22.6x | -1110.5x | 8x |
Sat, 08 May 2021 | US$1.4t | US$174.8b | -US$11,096,405,382.55 | 22.2x | -127.4x | 8.1x |
-125.6x
How does U.S. Biotech compare with similar industries?
US Market | -0.10% | |
Healthcare | -0.95% | |
Biotech | -2.11% | |
Biotech | -2.11% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
SGEN Seagen | US$228.74 | 4.5% +US$1.8b | 76.5% | PS18.8x | |
GERN Geron | US$3.36 | 57.0% +US$666.2m | 36.6% | PS7741.6x | |
BGNE BeiGene | US$170.00 | 3.3% +US$584.1m | -23.8% | PS7.2x | |
IMGN ImmunoGen | US$31.23 | 6.6% +US$516.6m | 617.9% | PS29.1x | |
TALS Talaris Therapeutics | US$27.20 | -4.9% US$430.9m | 91.5% | PB3.7x |